<DOC>
	<DOC>NCT00629681</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of pregabalin for the treatment of diabetic peripheral neuropathy (DPN) or postherpetic neuralgia (PHN)</brief_summary>
	<brief_title>A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Inclusion criteria: Diagnosis of DPN or PHN Score on the Numeric Rating Scale of at least 4/10 Hospitalized patients Neurologic disorders unrelated to DPN or PHN or any severe pain that may confound the assessment of DPN or PHNrelated pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>